161
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Antitumor activity and antioxidant role of a novel water-soluble carboxymethyl chitosan-based copolymer

, , &
Pages 1481-1490 | Received 07 Feb 2011, Accepted 05 May 2011, Published online: 27 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexandra Kodadová, Zuzana Vitková, Petra Herdová, Anton Ťažký, Jarmila Oremusová, Daniel Grančai & Peter Mikuš. (2015) Formulation of sage essential oil (Salvia officinalis, L.) monoterpenes into chitosan hydrogels and permeation study with GC-MS analysis. Drug Development and Industrial Pharmacy 41:7, pages 1080-1088.
Read now

Articles from other publishers (11)

Mohamed El-Far, Alaa Essam, Fardous F. El-Senduny, Amira O.Abd El-Azim, Sarah Yahia & Ibrahim M. El-Sherbiny. (2023) Novel highly effective combination of naturally-derived quercetin and ascorbyl palmitate and their nanoformulations as an advancement therapy of cancer. Journal of Drug Delivery Science and Technology 83, pages 104405.
Crossref
Sulekha Khute & Rajendra K. Jangde. (2023) Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design. Current Therapeutic Research 99, pages 100714.
Crossref
Mohamed El-Far, Alaa Essam, Fardous F. El-Senduny, Amira O. Abd El-Azim, Sarah Yahia & Ibrahim M. El-Sherbiny. (2022) Potential use of nanoformulated ascorbyl palmitate as a promising anticancer agent: First comparative assessment between nano and free forms. Journal of Drug Delivery Science and Technology 78, pages 103920.
Crossref
Sabya Sachi Das, Sweta Kar, Sandeep Kumar Singh, Afzal Hussain, P.R.P. Verma & Sarwar Beg. 2022. Chitosan in Drug Delivery. Chitosan in Drug Delivery 323 360 .
Shenouda G. Elia, Ahmed A. Al‐Karmalawy, Mohamed Y. Nasr & Mohamed F. Elshal. (2021) Loperamide potentiates doxorubicin sensitivity in triple‐negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl‐2: In vitro and molecular docking study. Journal of Biochemical and Molecular Toxicology 36:1.
Crossref
Jin-Cheng LI, Xue-Rui JIANG, Zeng-Chao GUO, Hai-JUN ZHANG, Hui JIANG & Xue-Mei WANG. (2021) Cerium-based Dual-Modality Imaging Contrast Agent for Efficient Retention in Tumor Acidic Microenvironment. Chinese Journal of Analytical Chemistry 49:7, pages e21126-e21132.
Crossref
Mohamed El-Far, Neven Salah, Alaa Essam, Amira Abd El-Azim, Mahmoud Karam & Ibrahim M El-Sherbiny. (2019) Potential anticancer activity and mechanism of action of nanoformulated curcumin in experimental Ehrlich ascites carcinoma-bearing animals. Nanomedicine 14:5, pages 553-573.
Crossref
Mohamed El-Far, Neven Salah, Alaa Essam, Amira O Abd El-Azim & Ibrahim M El-Sherbiny. (2018) Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich ascites carcinoma-bearing animals. Nanomedicine 13:15, pages 1865-1858.
Crossref
Abanoub S. Sedeky, Islam A. Khalil, Amr Hefnawy & Ibrahim M. El-Sherbiny. (2018) Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line. European Journal of Pharmaceutical Sciences 118, pages 103-112.
Crossref
Shufang Dong, Xin Zhou & Jiying Yang. (2016) TAT modified and lipid – PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA. Biomedicine & Pharmacotherapy 84, pages 954-961.
Crossref
Salem A. Habib, Yassin A. Aggour & Hossam A. Taha. (2012) Downregulation of transforming growth factor-<i>β</i> (TGF-<i>β</i>) and vascular endothelial growth factor (VEGF) in ehrlich ascites carcinoma-bearing mice using stearic acid-grafted carboxymethyl chitosan (SA-CMC). Natural Science 04:11, pages 808-818.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.